TY - JOUR
T1 - Using state administrative and pharmacy data bases to develop a clinical decision support tool for schizophrenia guidelines
AU - Finnerty, Molly
AU - Altmansberger, Richard
AU - Bopp, James
AU - Carpinello, Sharon
AU - Docherty, John P.
AU - Fisher, William
AU - Jensen, Peter
AU - Krishnan, Parukutty
AU - Mittleman, Michael
AU - Olfson, Mark
AU - Tricarico, Joel
AU - White, Tom
AU - Felton, Chip
PY - 2002
Y1 - 2002
N2 - Administrative and pharmacy data bases represent a largely untapped resource for clinical decision support and quality improvement. In this study, we examined the feasibility of using New York State Office of Mental Health (NYSOMH) data bases to develop an automated clinical report to support implementation of schizophrenia guidelines. First we reviewed the structure of existing data bases for capacity and limitations in supporting guideline implementation. Second, we identified schizophrenia guideline recommendations and adherence measures that would be the focus of our implementation. Third, a preliminary report was programmed, based on operational definitions of the guideline recommendations. Finally, we developed user groups to define content and format of new reports, through an iterative process of field testing, feedback, and revision. Our experience suggests that administrative and pharmacy data bases, despite their limitations, can be used to develop guidelinebased clinical decision support tools for schizophrenia with high physician acceptability.
AB - Administrative and pharmacy data bases represent a largely untapped resource for clinical decision support and quality improvement. In this study, we examined the feasibility of using New York State Office of Mental Health (NYSOMH) data bases to develop an automated clinical report to support implementation of schizophrenia guidelines. First we reviewed the structure of existing data bases for capacity and limitations in supporting guideline implementation. Second, we identified schizophrenia guideline recommendations and adherence measures that would be the focus of our implementation. Third, a preliminary report was programmed, based on operational definitions of the guideline recommendations. Finally, we developed user groups to define content and format of new reports, through an iterative process of field testing, feedback, and revision. Our experience suggests that administrative and pharmacy data bases, despite their limitations, can be used to develop guidelinebased clinical decision support tools for schizophrenia with high physician acceptability.
KW - Antipsychotic agents
KW - Clinical decision support
KW - Evidence-based medicine
KW - Guideline adherence
KW - Guideline implementation
KW - Quality indicators
KW - Schizophrenia
UR - http://www.scopus.com/inward/record.url?scp=0035988526&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0035988526&partnerID=8YFLogxK
U2 - 10.1093/oxfordjournals.schbul.a006929
DO - 10.1093/oxfordjournals.schbul.a006929
M3 - Article
C2 - 12047025
AN - SCOPUS:0035988526
SN - 0586-7614
VL - 28
SP - 85
EP - 94
JO - Schizophrenia Bulletin
JF - Schizophrenia Bulletin
IS - 1
ER -